VBIV - יחס מחיר להכנסות VBI Vaccines, Inc.

The collapse of the partner network and the freezing of investments have created a critical backdrop for VBI Vaccines Inc. (VBIV). By comparing the P/S multiple trend on GURU.Markets, we see that the value of 0.20 corresponds to the current stability metric. Revenue stability relies on government vaccine orders, while technological superiority is based on robotic bioreactors that eliminate human error during drug packaging.
VBI Vaccines (VBIV) - פילוחי מדדים ודוחות פיננסיים

The P/S ratio compares the market value of a business to its revenue, measuring the premium the market is willing to pay for every dollar of actual sales. By analyzing the P/S level of VBI Vaccines Inc. (VBIV) on the GURU.Markets platform, an investor assesses the monetization efficiency of the proprietary eVLP platform and the potential of VBI Vaccines Inc. (VBIV) long-term contracts with medical centers, which is critical for valuing a biopharmaceutical startup.